Do sustainability and fashion go hand in hand? Sustainable fashion and engaging with it, is a complex process – and there is no ‘one fits all’ solution – it requires a collaborative approach from business, consumers and policymakers. In this blog, Dr Claudia E Henninger examines the relationship between fashion and sustainability, and highlights opportunities […]
Data directly from our patients: Is improving patient data the key to better cancer care?
To provide the best care and support for cancer patients during and after treatment, it is essential to collect and work with data that captures patient experiences and patient-reported outcomes. But data is not a simple subject. The way healthcare services work with data, and how we work with patients to collect it, must be […]
Race equality in Greater Manchester: opportunities and challenges of collaboration
In 2021 the report of the Independent Inequalities Commission for Greater Manchester emphasised the need to put wellbeing and equality goals at the heart of the Greater Manchester Strategy. They recommended the development of a Race Equality Strategy. This led to a collaboration between the Greater Manchester Combined Authority (GMCA) and the Centre for Dynamics […]
Gender equality and the productivity agenda
The implications for gender equality are rarely discussed in the new productivity and levelling up agenda. It is key for productivity and levelling up policy agendas to address the underutilisation of women’s potential and the undervaluation of women’s work. In this blog, Professor Jill Rubery from the Work Equalities Institute investigates the underutilisation of women […]
Rules of the road: The need for new quality standards for AI technology in healthcare
In recent years, we have seen a profusion of AI, algorithm, and machine-learning technologies enter clinical practice. This has happened across the health and care sector, and cancer testing and treatments have been no exception, with some proven benefits. For example, AI has been shown to be capable of recognising patterns in scan images that […]
Advanced radiotherapies: What are the challenges and opportunities?
Advanced radiotherapies are redefining the kinds of cancer treatment that are possible. These developments are exciting, but they also present new challenges. One challenge for researchers and clinicians is how to support policymakers, tasked with developing treatment and care standards across the NHS. So, what are these new treatments, what do they mean for patient […]
How public procurement can influence innovation, productivity and societal challenges
The public sector is an extremely influential buyer in the market. Through public procurement, the government can influence productivity in various ways. It can develop and scale up productivity-enhancing innovations, and it can reward more innovative suppliers by shaping markets and amplifying innovative practices and technologies. Her applicable policy recommendations focus on improving poignance of […]
Nuclear power – the role of government
In 2006, Prime Minister Tony Blair assured Britain that nuclear was “back on the agenda with a vengeance”. Boris Johnson has described his commitment to deliver nuclear at “warp speed”, and the three intervening Prime Ministers have also emphasised their support for nuclear. Yet Britain’s first new nuclear plant – Hinkley Point C (HPC) – […]
Access and inclusion: Can we move cancer services closer to home?
Traditionally, the vast majority of cancer services take place in hospitals, but new thinking and new technology are rapidly changing this landscape, particularly because of the impact of COVID-19 on the delivery of healthcare services. In this blog, from our On Cancer publication, Dr Philip Crosbie and Dr Dónal Landers outlines how delivering services at […]
Disadvantage and disease: finding solutions to inequalities in cancer
The COVID-19 pandemic has brought renewed focus to the great health inequalities between different communities in our society. Looking at cancer care, these inequalities exist across the whole cancer pathway from uptake in screening, likelihood to present early with symptoms, participation in clinical trials, diagnosis and access to treatments. In this blog, from our On […]
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 168
- Next Page »